Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,748,195 papers from all fields of science
Search
Sign In
Create Free Account
tilisolol
Known as:
1(2H)-Isoquinolinone, 4-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-2-methyl-
, 4-(3(tert-butylamino)-2-hydroxypropoxy)-N-methylisocarbostyril
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Isoquinolines
Narrower (1)
N 696
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Transport of timolol and tilisolol in rabbit corneal epithelium.
K. Sakanaka
,
K. Kawazu
,
+6 authors
H. Sasaki
Biological and Pharmaceutical Bulletin
2006
Corpus ID: 10708120
The purpose of this study is to characterize the transport of tilisolol and timolol through the corneal epithelium, which is…
Expand
2003
2003
One-side-coated insert as a unique ophthalmic drug delivery system.
H. Sasaki
,
T. Nagano
,
+7 authors
M. Nakashima
Journal of Controlled Release
2003
Corpus ID: 25117326
2001
2001
Ocular absorption behavior of palmitoyl tilisolol, an amphiphilic prodrug of tilisolol, for ocular drug delivery.
S. Kawakami
,
K. Nishida
,
+6 authors
H. Sasaki
Journal of Pharmacy and Science
2001
Corpus ID: 19226979
The objective of this study was to examine the ocular absorption behavior of an amphiphilic prodrug after instillation onto the…
Expand
2001
2001
Controlled release and ocular absorption of tilisolol utilizing ophthalmic insert-incorporated lipophilic prodrugs.
S. Kawakami
,
K. Nishida
,
+5 authors
H. Sasaki
Journal of Controlled Release
2001
Corpus ID: 31777936
2000
2000
Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
H. Sasaki
,
K. Yamamura
,
+4 authors
M. Ichikawa
Biological and Pharmaceutical Bulletin
2000
Corpus ID: 38337061
We previously developed an in vivo pharmacokinetic model that accounts for the corneal diffusion in albino rabbits and predicts…
Expand
1999
1999
Characterization of Ocular Pharmacokinetics of Beta-Blockers Using a Diffusion Model After Instillation
K. Yamamura
,
H. Sasaki
,
+4 authors
J. Nakamura
Pharmaceutical Research
1999
Corpus ID: 39308120
AbstractPurpose. To characterize the ocular pharmacokinetics of beta-blockers (timolol and tilisolol) after instillation in the…
Expand
1999
1999
Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits.
H. Sasaki
,
K. Yamamura
,
+4 authors
M. Ichikawa
Biological and Pharmaceutical Bulletin
1999
Corpus ID: 29191497
The purpose of this study was to characterize the ocular pharmacokinetics of a beta-blocker, tilisolol, after instillation into…
Expand
1997
1997
Effects of tilisolol, a nonselective beta-adrenergic blocker, on the membrane currents of isolated guinea pig ventricular myocytes.
S. Takagi
,
Y. Kihara
,
T. Mitsuiye
,
Z. Wang
,
S. Sasayama
Journal of Cardiovascular Pharmacology
1997
Corpus ID: 24022085
The effects of tilisolol, a nonselective beta-adrenoceptor blocker, on transmembrane ionic currents were studied in single guinea…
Expand
1996
1996
Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K+-channel opening mechanism in dogs
Quan Liu
,
I. Nakae
,
Masayuki Takahashi
,
A. Takaoka
,
M. Kinoshita
Cardiovascular Drugs and Therapy
1996
Corpus ID: 23577167
SummaryTilisolol is a beta-blocking agent with vasodilatory properties that was recently shown to possess a potassium (K…
Expand
1995
1995
Ophthalmic Preservatives as Absorption Promoters for Ocular Drug Delivery
H. Sasaki
,
T. Nagano
,
K. Yamamura
,
K. Nishida
,
J. Nakamura
The Journal of pharmacy and pharmacology
1995
Corpus ID: 40558564
The effects of ophthalmic preservatives on the drug permeability through isolated ocular membranes of albino rabbits were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE